PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,031 | +273.3% | 13,725 | +433.8% | 0.00% | – |
| Q2 2023 | $2,419 | +7459.4% | 2,571 | -92.2% | 0.00% | -100.0% |
| Q1 2023 | $32 | -46.7% | 33,049 | -24.2% | 0.00% | -50.0% |
| Q4 2022 | $60 | -99.9% | 43,596 | +4.7% | 0.00% | +100.0% |
| Q3 2022 | $52,000 | +2.0% | 41,625 | +89.9% | 0.00% | 0.0% |
| Q2 2022 | $51,000 | +6.2% | 21,919 | +41.2% | 0.00% | – |
| Q1 2022 | $48,000 | +380.0% | 15,523 | +865.4% | 0.00% | – |
| Q4 2021 | $10,000 | -54.5% | 1,608 | -26.1% | 0.00% | -100.0% |
| Q3 2021 | $22,000 | -72.8% | 2,177 | -64.6% | 0.00% | -50.0% |
| Q2 2021 | $81,000 | +47.3% | 6,142 | +97.0% | 0.00% | +100.0% |
| Q1 2021 | $55,000 | +139.1% | 3,118 | +250.7% | 0.00% | 0.0% |
| Q4 2020 | $23,000 | -85.8% | 889 | -92.8% | 0.00% | -50.0% |
| Q3 2020 | $162,000 | +671.4% | 12,382 | +1508.1% | 0.00% | +100.0% |
| Q2 2020 | $21,000 | +950.0% | 770 | +427.4% | 0.00% | – |
| Q1 2020 | $2,000 | – | 146 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $4,668,631 | 5.54% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $2,348,047 | 2.02% |
| BML Capital Management, LLC | 2,058,767 | $1,937,917 | 1.74% |
| Lynx1 Capital Management LP | 1,167,343 | $1,098,820 | 0.72% |
| Acuitas Investments, LLC | 418,173 | $393,626 | 0.23% |
| Orbimed Advisors | 10,124,576 | $9,530,263 | 0.17% |
| Frazier Life Sciences Management, L.P. | 1,850,000 | $1,741,405 | 0.10% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $282,390 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $80,999 | 0.02% |
| Annandale Capital, LLC | 54,338 | $51 | 0.02% |